We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
-5.23%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$193M
AUM Growth
-$10.1M
Cap. Flow
+$2.63M
Cap. Flow %
1.36%
Top 10 Hldgs %
31.8%
Holding
959
New
42
Increased
148
Reduced
234
Closed
41

Top Sells

Rank Stock Value
1
SAP icon
SAP
SAP
+$1.27M
2
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
+$1M
3
T icon
AT&T
T
+$626K
4
WBD icon
Warner Bros
WBD
+$110K
5
COP icon
ConocoPhillips
COP
+$102K

Sector Composition

Rank Sector Weight
1 Technology 35.63%
2 Healthcare 14.02%
3 Consumer Staples 7.64%
4 Financials 7.01%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXP icon
576
Eagle Materials
EXP
$6.49B
$6K ﹤0.01%
52
-1
-2% -$120
FCPT icon
577
Four Corners Property Trust
FCPT
$2.89B
$6K ﹤0.01%
224
GLOB icon
578
Globant
GLOB
$1.65B
$6K ﹤0.01%
31
+4
+15% +$825
IDA icon
579
Idacorp
IDA
$8B
$6K ﹤0.01%
58
-1
-2% -$109
ILMN icon
580
Illumina
ILMN
$29.5B
$6K ﹤0.01%
34
-2
-6% -$396
IR icon
581
Ingersoll Rand
IR
$33.1B
$6K ﹤0.01%
143
-2
-1% -$94
IWM icon
582
iShares Russell 2000 ETF
IWM
$79.1B
$6K ﹤0.01%
35
JAZZ icon
583
Jazz Pharmaceuticals
JAZZ
$16.1B
$6K ﹤0.01%
48
-10
-17% -$1.52K
LAD icon
584
Lithia Motors
LAD
$9.75B
$6K ﹤0.01%
27
MCY icon
585
Mercury Insurance
MCY
$6B
$6K ﹤0.01%
200
MRVL icon
586
Marvell Technology
MRVL
$147B
$6K ﹤0.01%
133
MS icon
587
Morgan Stanley
MS
$319B
$6K ﹤0.01%
81
-30
-27% -$2.53K
NTLA icon
588
Intellia Therapeutics
NTLA
$1.51B
$6K ﹤0.01%
100
OLN icon
589
Olin
OLN
$2.53B
$6K ﹤0.01%
147
+32
+28% +$1.62K
PFGC icon
590
Performance Food Group
PFGC
$18.3B
$6K ﹤0.01%
132
PII icon
591
Polaris
PII
$3.83B
$6K ﹤0.01%
61
-1
-2% -$112
QUAL icon
592
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$6K ﹤0.01%
59
RBA icon
593
RB Global
RBA
$21.5B
$6K ﹤0.01%
90
-2
-2% -$136
SHW icon
594
Sherwin-Williams
SHW
$84.8B
$6K ﹤0.01%
30
TAK icon
595
Takeda Pharmaceutical
TAK
$56.7B
$6K ﹤0.01%
460
UNIT
596
Uniti Group
UNIT
$2.52B
$6K ﹤0.01%
923
-923
-50% -$8.57K
USFD icon
597
US Foods
USFD
$22.5B
$6K ﹤0.01%
238
-45
-16% -$1.4K
VECO icon
598
Veeco
VECO
$2.62B
$6K ﹤0.01%
350
CTLT
599
DELISTED
CATALENT, INC.
CTLT
$6K ﹤0.01%
76
-10
-12% -$993
HZNP
600
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6K ﹤0.01%
95
-7
-7% -$489

Similar funds

Front Row Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Front Row Advisors held 959 positions worth $193M, down 5% from $203M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Front Row Advisors's Q3 2022 filing shows 42 new, 148 increased, 234 reduced and 41 closed positions. Its largest new stake was ProShares UltraShort S&P500: 650 shares worth $177K. The largest sale was SAP, an estimated $1.27M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q3 2022 buy was ProShares UltraShort S&P500: 650 shares worth $177K.
  • Front Row Advisors added most to Packaging Corp of America in Q3 2022, an estimated $2.25M increase.
  • Front Row Advisors's biggest Q3 2022 reduction was SAP, cutting an estimated $1.27M.
  • Front Row Advisors fully exited Valero Energy in Q3 2022, selling an estimated $99K.
  • Front Row Advisors's ten largest holdings make up 32% of its $193M portfolio in Q3 2022.
  • Front Row Advisors opened 42 new positions and closed 41 in Q3 2022.
  • Front Row Advisors's portfolio value fell 5% quarter-over-quarter to $193M.

Based on Front Row Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.